Our Oligonucleotide 2'-Modification Services help biotechnology teams, pharmaceutical research groups, CROs, academic laboratories, and platform developers build RNA and DNA/RNA chimeric oligonucleotides with fit-for-purpose sugar chemistry. Strategic replacement of the ribose 2'-hydroxyl group can improve nuclease resistance, tune duplex stability, alter protein interactions, and extend the usable lifetime of an oligonucleotide in demanding research workflows. The value of a 2'-modification depends on where it is placed, which strand carries it, the intended molecular mechanism, and how it interacts with backbone, terminal, or conjugation chemistries.
Our platform connects modification-pattern design with custom oligonucleotide synthesis, purification, analytical confirmation, and application-aware technical review. We support 2'-O-methyl (2'-OMe), 2'-fluoro (2'-F), 2'-O-methoxyethyl (2'-MOE), mixed 2'-chemistry patterns, and selected specialty analogs after feasibility assessment. Projects can be coordinated with broader DNA/RNA modification services when the construct also requires phosphorothioate linkages, terminal groups, labels, spacers, or conjugation handles.
Choosing the Right 2'-Chemistry: 2'-OMe, 2'-F, and 2'-MOE do not produce identical effects. Customers must balance nuclease resistance, target affinity, steric demand, strand function, and cost rather than selecting a modification only because it is widely used. We review the intended assay and mechanism before recommending a chemistry or mixed pattern.
Preserving the Intended Mechanism: A fully sugar-modified oligonucleotide may be suitable for steric blocking, duplex stabilization, or RNA interference workflows, but it does not automatically support every enzyme-dependent mechanism. For RNase H-recruiting antisense designs, the modified wings and central DNA gap must be planned together so stability gains do not remove the required cleavage-competent region.
Managing Sequence-Dependent Synthesis: Long sequences, dense modification patterns, high-GC regions, and mixed monomer sets can increase coupling, deprotection, and full-length yield challenges. We assess sequence composition, modification density, and compatible synthesis cycles before execution to reduce avoidable redesign and material loss.
Separating Closely Related Impurities: Truncated products, deletion sequences, incomplete deprotection products, and modification-related by-products may have chromatographic behavior close to the target oligonucleotide. Purification strategy is therefore selected according to length, charge, hydrophobicity, modification pattern, and required downstream use rather than by a single default method.
Translating Chemistry Into Assay Performance: Increased duplex stability is not always equivalent to better experimental performance. Excess affinity, altered strand loading, reduced enzyme compatibility, or changed secondary structure can create new limitations. We help customers define comparison controls, modification maps, and fit-for-use analytical criteria before moving into larger studies.
Our service model supports both customer-specified constructs and projects that require chemistry selection before synthesis. Each program is reviewed for sequence context, intended mechanism, modification placement, purification needs, analytical expectations, and compatibility with downstream biochemical or cell-based research.
Deliverables can include design recommendations, annotated sequence maps, purified oligonucleotide material, analytical data, handling guidance, and a structured technical summary for internal R&D or procurement review.
| 2'-Modifications | Short Code | Unit Molecular Weight: | Price |
| 2'-Amino-butyryl-pyrene-uridine | 2'-P-U | 575.51 | Inquiry |
| 2'-Amino-cytidine | 2'-N-C | 304.20 | Inquiry |
| 2'-Amino-uridine | 2'-N-U | 305.18 | Inquiry |
| 2'-Deoxy-uridine | dU | 290.17 | Inquiry |
| 2'-Fluoro-adenosine | 2'-F-A | 331.20 | Inquiry |
| 2'-Fluoro-cytidine | 2'-F-C | 307.17 | Inquiry |
| 2'-Fluoro-guanosine | 2'-F-G | 347.20 | Inquiry |
| 2'-Fluoro-uridine | 2'-F-U | 308.16 | Inquiry |
| 2'-OMe-inosine | mI | 344.22 | Inquiry |
The most suitable 2'-chemistry depends on the target, molecular mechanism, strand role, required stability, and acceptable synthesis complexity. The matrix below provides a practical starting point for project discussion; final placement should be evaluated in the full sequence context.
| Modification Format | Structural Change | Primary Design Value | Important Constraints | Common Research Uses |
| 2'-O-Methyl (2'-OMe) | Replaces the ribose 2'-OH hydrogen with a methyl group | Improves nuclease resistance and supports stronger RNA-target duplexes with moderate steric demand | Fully modified constructs do not provide an RNase H-active DNA region; placement can affect RNA-protein interactions | siRNA, miRNA inhibitors, guide RNAs, steric blockers, probes, RNA stability studies |
| 2'-Fluoro (2'-F) | Replaces the ribose 2'-OH with fluorine | Provides strong conformational preorganization, increased duplex stability, and improved nuclease resistance | Position and strand effects require empirical review; dense patterns can increase synthesis and purification demands | siRNA, aptamers, high-affinity RNA binders, structural studies |
| 2'-O-Methoxyethyl (2'-MOE) | Adds a methoxyethyl substituent through the ribose 2'-oxygen | Supports high RNA affinity and strong nuclease resistance in affinity-enhanced designs | Bulkier chemistry can affect coupling, purification, and overall construct design; fully modified regions do not recruit RNase H | Antisense wings, steric blockers, aptamers, high-affinity probes |
| Mixed 2'-OMe/2'-F | Alternates or patterns two sugar modifications within one strand or duplex | Balances stability, affinity, strand function, and sequence-dependent performance | A universal pattern is not appropriate for every sequence; strand asymmetry and positional effects must be considered | Chemically stabilized siRNA, aptamers, comparative modification screening |
| 2'-Modified/DNA Gapmer | Places 2'-modified nucleotides in terminal wings around a central DNA segment | Combines terminal affinity and stability with an RNase H-compatible central region | Wing length, gap length, target site, and backbone pattern jointly influence activity and selectivity | RNase H-dependent antisense research and candidate screening |
| Specialty 2'-Analogs | Introduces project-specific 2'-substituents or constrained sugar analogs | Enables click chemistry, mechanistic studies, affinity tuning, or custom structure-function questions | Monomer availability, coupling compatibility, deprotection, purification, and analytical interpretation require feasibility review | Chemical biology tools, custom probes, conjugation-ready oligos, exploratory platform research |
Successful modified-oligo programs require more than a sequence and a purity target. The following planning areas connect modification chemistry with manufacturability, analytical confidence, and downstream experimental use.
| Decision Area | What We Evaluate | Why It Matters | Typical Deliverable | Project Stage |
| Sequence and Target Review | Length, GC content, repeats, target accessibility, self-complementarity, and sequence uniqueness | Identifies design risks before modified monomers and purification resources are committed | Feasibility comments and candidate-priority recommendations | Planning |
| Modification Map | Chemistry type, position, strand, density, terminal placement, and mixed-pattern logic | Aligns stability and affinity goals with the intended molecular mechanism | Annotated sequence and alternative pattern options | Design |
| Chemistry Compatibility | Monomer set, coupling cycle, protecting groups, cleavage conditions, and coexisting modifications | Reduces incompatibility between sugar chemistry, labels, backbone changes, and terminal groups | Synthesis route and technical risk notes | Pre-Synthesis |
| Purification Strategy | Target length, charge, hydrophobicity, truncation profile, and required final form | Helps separate the full-length product from closely related process impurities | Fit-for-purpose purification plan | Synthesis |
| Identity and Purity | Expected mass, chromatographic profile, concentration basis, and agreed acceptance criteria | Confirms that the delivered material matches the designed construct | Mass and chromatographic analytical package | Quality Review |
| Duplex Behavior | Complementarity, modification density, mismatch position, strand balance, and optional melting analysis | Detects cases where added affinity may alter specificity or functional strand behavior | Comparison plan or optional duplex-performance data | Validation |
| Assay Compatibility | Enzymes, proteins, buffers, matrices, readouts, delivery format, and handling conditions | Prevents chemistry choices that conflict with the customer's downstream workflow | Fit-for-use recommendations and control suggestions | Application Setup |
| Scale Progression | Material demand, synthesis complexity, purification recovery, formulation, and documentation needs | Supports transfer from initial screening quantities to larger research batches | Scale-up assessment and revised execution plan | Follow-On Research |
Our workflow connects sequence intent, modification chemistry, synthesis execution, purification, and analytical review. Each stage is used to resolve a specific technical risk and provide customers with clear decision points.
We collect the sequence, strand format, target, intended mechanism, desired scale, purity expectation, and downstream assay conditions. This establishes whether the project needs direct execution, design support, or a comparison panel.
Our team reviews 2'-chemistry options, modification density, RNase H requirements, strand-specific considerations, coexisting backbone or terminal modifications, and sequence-dependent synthesis risks. Customers receive a practical route rather than a generic modification recommendation.
The final sequence map, modification positions, candidate set, purification approach, analytical plan, and deliverables are confirmed before synthesis. This step reduces ambiguity between scientific design and production instructions.
The oligonucleotide is synthesized using cycles and deprotection conditions selected for the monomer set and construct complexity. Purification is then applied according to the expected impurity profile and required experimental use.
Identity, chromatographic purity, concentration basis, duplex preparation, or other agreed attributes are reviewed against the project plan. Any relevant handling or interpretation notes are captured before release.
Final material and documentation are delivered in the agreed format. Post-delivery support can address reconstitution, control selection, pattern comparison, troubleshooting, or planning for a follow-on synthesis scale.
We approach 2'-modified oligonucleotides as integrated design-and-synthesis projects. The objective is not simply to insert modified bases, but to deliver a construct whose chemistry, analytical profile, and downstream use are aligned.
2'-modifications are used when unmodified RNA does not provide sufficient stability, affinity, or workflow robustness. The final pattern should remain application-specific because the same chemistry can behave differently across sequences, strands, and assay systems.
Whether your project requires a defined 2'-OMe sequence, a mixed 2'-F/2'-OMe siRNA pattern, a 2'-MOE winged gapmer, a stabilized guide RNA, or a custom comparison panel, our team can connect chemistry selection with synthesis, purification, and analytical review. Share your sequence, intended mechanism, modification concept, target quantity, and downstream workflow so we can identify technical risks and propose a practical execution plan. Contact us to discuss your 2'-modified oligonucleotide requirements.
2' modifications significantly enhance oligonucleotide stability and nuclease resistance. They also improve binding affinity to RNA targets for better assay performance.
2'-F modifications increase duplex stability while maintaining RNA-like conformation. 2'-OMe provides enhanced nuclease resistance and reduced immune stimulation.
2'-OMe modifications are ideal for siRNA strands to improve stability and reduce off-target effects. We recommend position-specific modifications to maintain RISC activity.
Yes, we routinely combine 2' modifications with backbone and base modifications. This creates synergistic effects for optimal oligo performance.
Loading ......
